The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 2.29 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -2.35 — no flag raisedOK
Where the revenue comes from
Fiscal 2025, as BECTON DICKINSON & CO reports it. History and quarterly detail are in the app.
- Medical$11.5B
- Interventional$5.2B
- Life Sciences$5.2B
Leadership changes
From BECTON DICKINSON & CO's own filings, the day they're filed.
- Jacqueline Wright · Directors · appointmenteff. 2025-12-01
- Robert L. Huffines · Directors · appointmenteff. 2025-12-01
- Gregory J. Hayes · Directors · appointmenteff. 2025-03-26
Latest filings
- 8-K · Company announcement2026-05-29
- 8-K · Company announcement2026-05-20
- 8-K · Company announcement2026-05-12
- 8-K · Company announcement2026-05-07
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about BECTON DICKINSON & CO, every answer cited🔒
- The Intelligence Brief — added when BECTON DICKINSON & CO's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.